Bio Protocol (@bioprotocol): Using an AI-driven yeast-based drug screening, Curetopia identified multiple lead drug candidates for AARS2 deficiency
Estimated coin impact
Scores are not price-change percentages. High impact means a score of +70 or more, or -70 or less.
Impact unavailable
Using an AI-driven yeast-based drug screening, Curetopia identified multiple lead drug candidates for AARS2 deficiency ⚡ One FDA-approved drug, already safe for humans and fast-tracked ⚡ One globally approved drug, available even sooner No research paper, just a real, actionable path to treatment.